PT-141
Approvedaka Bremelanotide, Vyleesi
Approved libido peptide. Works on the brain, not the plumbing.
Mechanism
A melanocortin agonist that acts in the central nervous system to raise desire and arousal, a different route than the Viagra-style blood-flow drugs. It works on wanting, not just mechanics.
Regulatory & Safety Status
Approved as Vyleesi for low sexual desire (HSDD) in premenopausal women. Prescription drug. Flushing and nausea are common, fair warning.
Research
Comprehensive characterization of bremelanotide acetate and its degradants by LC-HRMS/MS and predicting epimerization through computational modelling
Goldilocks-Inspired Design of Mid-Size Macrocycles for Selective Targeting of Human Melanocortin Receptors
Clinical trial evidence on emerging pharmacological therapies for hypoactive sexual desire disorder in women: a systematic review and analysis of completed studies registered on ClinicalTrials.gov
Quantification of "Mercy Sex" in Heterosexual Women
Latest bremelanotide research